Home
Conditions
Immunoblastic Lymphadenopathy

Clinical trial condition

Immunoblastic Lymphadenopathy

Explore clinical trials studying Immunoblastic Lymphadenopathy. Study availability and eligibility vary by location and protocol.

192 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Immunoblastic Lymphadenopathy trial results

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

NCT01053494

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

NCT01129193

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +118 more
Locations: The Ohio State University James Cancer Hospital Columbus, Ohio, United States

View Trial Details

Completed

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00963274

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +23 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

University of North Carolina Chapel Hill, North Carolina, United States

Vanderbilt-Ingram Cancer Center, Vanderbilt University Nashville, Tennessee, United States

View Trial Details

Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions: Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

NCT00569309

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +27 more
Locations: Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations: Institut Jules Bordet Brussels, Belgium

CHU de Grenoble - Hopital de la Tronche Grenoble, France

German Hodgkin's Lymphoma Study Group Cologne, Germany

Ospedale San Martino Genoa, Italy

View Trial Details

Completed

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00301951

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +55 more
Locations: UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

NCT01254578

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

NCT00072514

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Immunoblastic Lymphadenopathy

Immunoblastic Lymphadenopathy trial results

Related conditions